30.06.2014 Views

Abstracts - Society for Developmental Biology

Abstracts - Society for Developmental Biology

Abstracts - Society for Developmental Biology

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

143<br />

with <strong>for</strong>k retarding Replication Slow Zones RSZs/Fragile sites and cis suppressors of viral Oris. Systematization of<br />

chromosome biology by scoring lesions/microarray analysis in combinations of Collaborative Cross Strain genomes and Y<br />

chromosomes represents an unbiased integrative approach taking advantage of the breadth of evolutionarily selected dysregulation.<br />

Program/Abstract # 432<br />

Mechanisms of ROS mediated longevity in C. elegans<br />

Yee, Callista; Yang, Wen; Hekimi, Siegfried, McGill University, Montreal, Canada<br />

Aging is a natural process that occurs in most species and despite years of research, is a process which is still poorly<br />

understood. Previous research using model organisms has identified three pathways which can affect aging: caloric<br />

restriction, insulin/IGF-1 signalling, and mitochondrial signalling. In C. elegans, two mutations that affect mitochondrial<br />

electron transport chain subunits result in increased production of reactive oxygen species (ROS). Animals carrying these<br />

mutations have a significantly enhanced lifespan relative to the wild type. It has also been shown that treatment with prooxidants<br />

such as paraquat (PQ) can significantly increase wild type lifespan but has no effect on the lifespan of these<br />

mitochondrial mutants. Furthermore, treatment with anti-oxidants such as N-acetyl-cysteine (NAC) and Vitamin C can<br />

decrease the longevity of these mutants to the wild-type level. These and other results suggest that increased levels of ROS<br />

act as a signal to extend lifespan in C. elegans. In order to determine the mechanisms involved in ROS signalling,<br />

microarrays were per<strong>for</strong>med on long-lived mitochondrial mutants and wild type animals treated with PQ. Between the two<br />

mitochondrial mutants tested, an 80% overlap of the genes that were upregulated was detected. Most significantly, 50% of<br />

the genes found in this overlap were also upregulated in the wild type animals treated with PQ. This pattern was also<br />

observed <strong>for</strong> downregulated genes. This suggests that the genes that were upregulated by both the mitochondrial mutations<br />

and by PQ (~500) are likely to be involved in ROS mediated longevity. An RNAi screen of the genes found to be<br />

commonly upregulated is currently being per<strong>for</strong>med in the mutant backgrounds.<br />

Program/Abstract # 433<br />

Characterising the role of a regulator of G protein signalling in cranial sensory ganglia <strong>for</strong>mation<br />

Fleenor, Stephen; Begbie, Jo, University of Ox<strong>for</strong>d, Ox<strong>for</strong>d, United Kingdom<br />

The cranial sensory ganglia, which are responsible <strong>for</strong> relaying a variety of sensations in the head, <strong>for</strong>m in part by<br />

migration of neuroblasts delaminating from specialised thickenings of surface ectoderm called placodes. Here we<br />

investigate the molecular mechanisms governing neuroblast generation and migration from the placode in the developing<br />

chick embryo by characterising the role of a regulator of G protein signalling, RGS3. We initially identified RGS3 in a<br />

microarray screening <strong>for</strong> molecules upregulated during neuroblast migration. We show it to be specifically expressed in<br />

cranial sensory neuroblasts during ganglia <strong>for</strong>mation. In addition, knockdown of RGS3 expression via short-hairpin RNA<br />

results unexpectedly in precocious extension of axon projections and neuroblast migration. Future work elucidating this<br />

function will include differential analysis of naturally-occurring iso<strong>for</strong>ms of RGS3, as well as the broader role RGS3 may<br />

play in G protein signalling.<br />

Program/Abstract # 434<br />

The role of NFAT/calcium pathway during kidney development and polycystic kidney disease<br />

Saban, Jeremy; Miller, Michelle; Corsini, Rachel; Iglesias, Diana; Goodyer, Paul (MCHRI, Westmount, Canada)<br />

In 2005, Simons et al. proposed that during kidney development there is a switch from canonical to non-canonical Wnt<br />

signalling. Failure to do so could result in a cystic kidney phenotype. Our lab described that canonical Wnt signalling is<br />

high during normal kidney development and is down regulated once nephrogenesis is completed. This is also the case in<br />

two mouse models of polycystic kidney disease (PKD). We hypothesize that non-canonical Wnt signalling could be<br />

abnormally regulated in PKD. We studied the role of the NFAT/calcium non canonical pathway during kidney<br />

development and explored a potential role in PKD. We employed an NFAT-luciferase reporter mouse, where NFAT is the<br />

primary downstream signaling molecule of the Wnt-calcium pathway. We found that Wnt/calcium signaling peaks from<br />

embryonic day E13-E16 in wild type embryonic mouse kidneys. This reporter was responsive to non-canonical Wnts such<br />

as Wnt5a and Wnt11, and the effect of the Wnts could be abrogated by cyclosporin-A, a specific inhibitor of the pathway.<br />

To study the functional role of this pathway in the developing kidney, we examined Wnt-calcium signaling in different<br />

kidney cell lines, finding that turning on the Wnt-calcium pathway restricts cell motility, without affecting cell proliferation<br />

or apoptosis. In addition, in situ hybridization showed that Wnt-calcium signaling is located in the nephrogenic zone;<br />

however, preliminary data shows that activity seems to be located in the ureteric bud (UB) cells. This may indicate Wntcalcium<br />

signaling is active at the UB tips and could be involved in branching morphogenesis. Preliminary data indicates<br />

that the pathway may be down regulated in a polycystic kidney disease mouse model.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!